In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine

Por Schader, Susan M., Oliveira, Maureen, Ibanescu, Ruxandra-Ilinca, Moisi, Daniela, Colby-Germinario, Susan P., Wainberg, Mark A.
Publicado em 2012

HIV gp120 H375 Is Unique to HIV-1 Subtype CRF01_AE and Confers Strong Resistance to the Entry Inhibitor BMS-599793, a Candidate Microbicide Drug

Por Schader, Susan M., Colby-Germinario, Susan P., Quashie, Peter K., Oliveira, Maureen, Ibanescu, Ruxandra-Ilinca, Moisi, Daniela, Mespléde, Thibault, Wainberg, Mark A.
Publicado em 2012

Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1

Por Hassounah, Said A., Alikhani, Ahmad, Oliveira, Maureen, Bharaj, Simrat, Ibanescu, Ruxandra-Ilinca, Osman, Nathan, Xu, Hong-Tao, Brenner, Bluma G., Mesplède, Thibault, Wainberg, Mark A.
Publicado no Antimicrob Agents Chemother (2017)

Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors

Por Brenner, Bluma G., Thomas, Réjean, Blanco, José Luis, Ibanescu, Ruxandra-Ilinca, Oliveira, Maureen, Mesplède, Thibault, Golubkov, Olga, Roger, Michel, Garcia, Federico, Martinez, Esteban, Wainberg, Mark A.
Publicado no J Antimicrob Chemother (2016)

Basis for Early and Preferential Selection of the E138K Mutation in HIV-1 Reverse Transcriptase

Por McCallum, Matthew, Oliveira, Maureen, Ibanescu, Ruxandra-Ilinca, Kramer, Victor G., Moisi, Daniela, Asahchop, Eugene L., Brenner, Bluma G., Harrigan, P. Richard, Xu, Hongtao, Wainberg, Mark A.
Publicado em 2013